# Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

> **NCT00482716** · PHASE3 · UNKNOWN · sponsor: **St. Bartholomew's Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Anemia
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** epoetin alfa
- **BIOLOGICAL:** epoetin beta
- **DIETARY_SUPPLEMENT:** iron dextran complex
- **DIETARY_SUPPLEMENT:** iron sucrose injection

## Key facts

- **NCT ID:** NCT00482716
- **Lead sponsor:** St. Bartholomew's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2014-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00482716

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00482716, "Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT00482716. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*